Circulating markers of inflammation are related to carotid artery atherosclerosis

International Angiology

Volumn 24, Issue 1, 2005, Pages 43-51

  Larsson, P Thomas ^a   Hallerstam, S ^a   Rosfors, S ^a   Wallen N H ^b,c  

^a KAROLINSKA INSTITUTE   (Sweden)

^b KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

^c DANDERYD HOSPITAL   (Sweden)

Author keywords

Atherosclerosis; Carotid artery; Cell adhesion molecules; Cytokines; Inflammation; Platelets, physiology; Ultrasonography

Indexed keywords

ACETYLSALICYLIC ACID; ANTILIPEMIC AGENT; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; C REACTIVE PROTEIN; CALCIUM CHANNEL BLOCKING AGENT; CALPROTECTIN; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; DIURETIC AGENT; FIBRINOGEN; INTERCELLULAR ADHESION MOLECULE 1; INTERLEUKIN 6; INTERLEUKIN 8; MONOCYTE CHEMOTACTIC PROTEIN 1; NITRIC ACID DERIVATIVE; PADGEM PROTEIN; SERUM AMYLOID A; TUMOR NECROSIS FACTOR ALPHA; VASCULAR CELL ADHESION MOLECULE 1;

ADULT; AGED; ARTERY DIAMETER; ARTERY INTIMA PROLIFERATION; ARTICLE; ATHEROSCLEROSIS; ATHEROSCLEROTIC PLAQUE; BLOOD SAMPLING; BODY MASS; CARDIOVASCULAR DISEASE; CAROTID ARTERY DISEASE; CONTROLLED STUDY; ECHOCARDIOGRAPHY; FEMALE; GENDER; HEMOSTASIS; HUMAN; LOW DRUG DOSE; MAJOR CLINICAL STUDY; MALE; NON INVASIVE MEASUREMENT; PREVALENCE; PROSPECTIVE STUDY; SMOKING;

ADULT; AGED; AGED, 80 AND OVER; BIOLOGICAL MARKERS; CAROTID ARTERIES; CAROTID ARTERY DISEASES; CELL ADHESION MOLECULES; CHEMOKINE CCL2; FEMALE; HEMOSTASIS; HUMANS; INFLAMMATION; INTERLEUKINS; MALE; MIDDLE AGED; PROSPECTIVE STUDIES; RISK FACTORS;

EID: 33646477216     PISSN: 03929590     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (33)

1. Salonen JT, Salonen R. Ultrasound B-mode imaging in observational studies of atherosclerotic progression. Circulation 1993;87:II56-65.
2. Bots ML, Hoes AW, Koudstaal PJ, Hofman A, Grobbee DE. Common carotid intima-media thickness and risk of stroke and myocardial infarction: the Rotterdam Study. Circulation 1997;96:1432-7.
3. O'Leary DH, Polak JF, Kronmal RA, Manolio TA, Burke GL, Wolfson SK Jr. Carotid-artery intima and media thickness as a risk factor for myocardial infarction and stroke in older adults. Cardiovascular Health Study Collaborative Research Group. N Engl J Med 1999;340:14-22.
4. Chambless LE, Folsom AR, Clegg LX, Sharrett AR, Shabar E, Nieto FJ et al. Carotid wall thickness is predictive of incident clinical stroke: the Atherosclerosis Risk in Communities (ARIC) study. Am J Epidemiol 2000;151: 478-87.
5. Held C, Hjemdahl P, Eriksson SV, Bjorkander I, Forslund L, Rehnqvist N. Prognostic implications of intima-media thickness and plaques in the carotid and femoral arteries in patients with stable angina pectoris. Eur Heart J 2001;22:62-72.
6. van der Meer IM, de Maat MP, Bots ML, Breteler MM, Meijer J, Kiliaan AJ et al. Inflammatory mediators and cell adhesion molecules as indicators of severity of atherosclerosis: the Rotterdam Study. Arterioscler Thromb Vasc Biol 2002;22:838-42.
7. De Caterina R, Basta G, Lazzerini G, Dell'Omo G, Petrucci R, Morale M et al. Soluble vascular cell adhesion molecule-1 as a biohumoral correlate of atherosclerosis. Arterioscler Thromb Vasc Biol 1997;17:2646-54.
8. Rohde LE, Lee RT, Rivero J, Jamacochian M, Arroyo LH, Briggs W et al. Circulating cell adhesion molecules are correlated with ultrasound-based assessment of carotid atherosclerosis. Arterioscler Thromb Vase Biol 1998;18: 1765-70.
9. Stenvinkel P, Heimburger O, Jogestrand T. Elevated interleukin-6 predicts progressive carotid artery atherosclerosis in dialysis patients: association with Chlamydia pneumoniae seropositivity. Am J Kidney Dis 2002;39: 274-82.
10. Kato A, Odamaki M, Takita T, Maruyama Y, Kumagai H, Hishida A. Association between interleukin-6 and carotid atherosclerosis in hemodialysis patients. Kidney Int 2002;61:1143-52.
11. Jogestrand T, Nowak J, Sylvén C. Improvement of common carotid intima+media complex measurements by calculating the cross-sectional area. J Vasc Invest 1995;1:193-5.
12. Glagov S, Weisenberg E, Zarins CK, Stankunavicius R, Kolettis GJ. Compensatory enlargement of human atherosclerotic coronary arteries. N Engl J Med 1987;316: 1371-5.
13. Labropoulos N, Zarge J, Mansour MA, Kang SS, Baker WH. Compensatory arterial enlargement is a common pathobiologic response in early atherosclerosis. Am J Surg 1998;176:140-3.
14. Nowak J, Nilsson T, Sylven C, Jogestrand T. Potential of carotid ultrasonography in the diagnosis of coronary artery disease: a comparison with exercise test and variance ECG. Stroke 1998;29:439-46.
15. Hallerstam S, Larsson PT, Zuber E, Rosfors S. Carotid atherosclerosis is correlated with extent and severity of coronary artery disease evaluated with myocardial perfusion scintigraphy. Angiology 2004;55:281-8.
16. Zuber E, Rosfors S. Effect of reversible hypoperfusion on left ventricular volumes measured with gated SPECT at rest and after adenosine infusion. J Nucl Cardiol 2000;7:655-60.
17. Wendelhag I, Gustavsson T, Suurkula M, Berglund G, Wikstrand J. Ultrasound measurement of wall thickness in the carotid artery: fundamental principles and description of a computerized analysing system. Clin Physiol 1991;11:565-77.
18. Lemne C, Jogestrand T, de Faire U. Carotid intima-media thickness and plaque in borderline hypertension. Stroke 1995;26:34-9.
19. Wendelhag I, Liang Q, Gustavsson T, Wikstrand J. A new automated computerized analyzing system simplifies readings and reduces the variability in ultrasound measurement of intima-media thickness. Stroke 1997;28: 2195-200.
20. Woods A, Brull DJ, Humphries SE, Montgomery HE. Genetics of inflammation and risk of coronary artery disease: the central role of interleukin-6. Eur Heart J 2000;21:1574-83.
21. Yudkin JS, Kumari M, Humphries SE, Mohamed-Ali V. Inflammation, obesity, stress and coronary heart disease: is interleukin-6 the link? Atherosclerosis 2000;148: 209-14.
22. Marz W, Winkler K, Nauck M, Bohm BO, Winkelmann BR. Effects of statins on C-reactive protein and interleukin-6 (the Ludwigshafen Risk and Cardiovascular Health study). Am J Cardiol 2003;92:305-8.
23. Kinlay S, Schwartz GG, Olsson AG, Rifai N, Leslie SJ, Sasiela WJ et al.; for the Myocardial Ischemia Reduction with Agressive Cholesterol Lowering (MIRACL) Study Investigators. High-dose atorvastatin enhances the decline in inflammatory markers in patients with acute coronary syndromes in the MIRACL study. Circulation 2003;108: 1560-6.
24. Tataru MC, Heinrich J, Junker R, Schulte H, von Eckardstein A, Assmann G et al. C-reactive protein and the severity of atherosclerosis in myocardial infarction patients with stable angina pectoris. Eur Heart J 2000;21: 1000-8.
25. Garcia-Moll X, Zouridakis E, Cole D, Kaski JC. C-reactive protein in patients with chronic stable angina: differences in baseline serum concentration between women and men. Eur Heart J 2000;21:1598-606.
26. Erren M, Reinecke H, Junker R, Fobker M, Schulte H, Schurek JO et al. Systemic inflammatory parameters in patients with atherosclerosis of the coronary and peripheral arteries. Arterioscler Thromb Vase Biol 1999;19: 2355-63.
27. Best PJ, Gersh BJ. Cell adhesion molecules and inflammation in acute coronary syndromes: markers and emerging risk factors. Eur Heart J 2001;22:1155-9.
28. Lagrand WK, Visser CA, Hermens WT, Niessen HWM, Verheugt FWA, Wolbink GJ et al. C-reactive protein as a cardiovascular risk factor. More than an epiphenomenon? Circulation 1999;100:96-102.
29. Ridker PM. Inflammation, atherosclerosis, and cardiovascular risk: an epidemiologic view. Blood Coagul Fibrinolysis 1999;10:S9-12.
30. Frijns CJM, Kappelle LJ, van Gijn J, Nieuwenhuis HK, Sixma JJ, Fijnheer R. Soluble adhesion molecules reflect endothelial cell activation in ischemic stroke and in carotid atherosclerosis. Stroke 1997;28:2214-8.
31. Ghaddar HB, Cortes J, Salomaa V, Kark JD, Davis CE, Folsom AR et al. Correlation of specific platelet activation markers with carotid arterial wall thickness. Thromb Haemost 1995;74:943-8.
32. Ramsis N, El-Hawary AA, Ismail E. Relation between carotid intima-media thickness, platelet surface activation and endothelial cell markers. Haemostasis 1998;28:268-75.
33. Ma J, Hennekens CH, Ridker PM, Stampfer MJ. A prospective study of fibrinogen and risk of myocardial infarction in the Physicians Health Study. J Am Coll Cardiol 1999;33:1347-52.